Anesthetic modulation of neuroinflammation in Alzheimer's disease

Current Opinion in Anaesthesiology

Volumn 24, Issue 4, 2011, Pages 389-394

  Tang, Junxia X ^a   Eckenhoff, Maryellen F ^a   Eckenhoff, Roderic G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cognitive dysfunction; cytokines; microglia; neurodegeneration; perioperative neurotoxicity; surgery

Indexed keywords

ANESTHETIC AGENT; ISOFLURANE; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ALZHEIMER DISEASE; ANESTHESIA; COGNITIVE DEFECT; GENERAL ANESTHESIA; HUMAN; LIFE EXPECTANCY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROSURGERY; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANESTHESIA; BLOOD-BRAIN BARRIER; BRAIN; COGNITION DISORDERS; HUMANS; INFLAMMATION; MICROGLIA; SURGICAL PROCEDURES, OPERATIVE;

EID: 79960698625     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32834871c5     Document Type: Review

References (70)

1. Prinz M, Mildner A. Microglia in the CNS: immigrants from another world. Glia 2011; 59:177-187.
2. Graeber MB. Changing face of microglia. Science 2010; 330:783-788.
3. Agostinho P, Cunha RA, Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 2010; 16:2766-2778.
4. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010; 119:7-35.
5. Schlachetzki JC, Hull M. Microglial activation in Alzheimer's disease. Curr Alzheimer Res 2009; 6:554-563.
6. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010; 6:193-201.
7. Imbimbo BP, Solfrizzi V, Panza F. Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? Front Aging Neurosci 2010; 2: 1-14.
8. Vlad SC, Miller DR, Kowall NW, et al. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008; 70:1672-1677. (Pubitemid 351644133)
9. Etminan M, Gill S, Samii A. Effect of nonsteroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. Br Med J 2003; 327:128.
10. Lindberg C, Selenica ML, Westlind-Danielsson A, et al. Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. J Mol Neurosci 2005; 27:1-12. (Pubitemid 41112374)
11. Sondag CM, Dhawan G, Combs CK. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 2009; 6:1.
12. Michelucci A, Heurtaux T, Grandbarbe L, et al. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 2009; 210:3-12.
13. Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 2009; 64:110-122.
14. Sparkman NL, Johnson RW. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 2008; 15:323-330.
15. Godbout JP, Chen J, Abraham J, et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 2005; 19:1329-1331. (Pubitemid 41113739)
16. Barrientos RM, Frank MG, Hein AM, et al. Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection. Brain Behav Immun 2009; 23:46-54.
17. Henry CJ, Huang Y, Wynne AM, et al. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 2009; 23:309-317.
18. Mouton PR, Kelley-Bell B, Tweedie D, et al. The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons. Neurobiol Aging 2010 [Epub ahead of print].
19. Sly LM, Krzesicki RF, Brashler JR, et al. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res Bull 2001; 56:581-588. (Pubitemid 34098810)
20. Kitazawa M, Oddo S, Yamasaki TR, et al. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25:8843-8853. (Pubitemid 41384452)
21. Herber DL, Mercer M, Roth LM, et al. Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol 2007; 2:222-231.
22. Lee DC, Rizer J, Selenica ML, et al. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 2010; 7:56.
23. Patel NS, Paris D, Mathura V, et al. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation 2005; 2:9.
24. Kiyota T, Okuyama S, Swan RJ, et al. CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APPPS1 bigenic mice. FASEB J 2010; 24:3093-3102.
25. Galasko D, Montine TJ. Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark Med 2010; 4:27-36.
26. Shaw LM, Korecka M, Clark CM, et al. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov 2007; 6:295-303. (Pubitemid 46505880)
27. Njie EG, Boelen E, Stassen FR, et al. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging 2010 [Epub ahead of print].
28. Streit WJ, Braak H, Xue QS, et al. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 2009; 118:475-485.
29. Bertram L, Tanzi RE. Alzheimer disease: new light on an old CLU. Nat Rev Neurol 2010; 6:11-13.
30. Hopfer H, Wiech T, Mihatsch MJ. Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type. Nephrol Dial Transplant 2011 [Epub ahead of print].
31. Perfetto F, Moggi-Pignone A, Livi R, et al. Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol 2010; 6:417-429.
32. Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010; 52:347-361.
33. Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2009; 6:608-617.
34. Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 1989; 341:226-230. (Pubitemid 19231721)
35. Arai H, Lee VM, Messinger ML, et al. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol 1991; 30:686-693.
36. Alvarez XA, Fernandez-Novoa L, Caamano J, et al. Cerebrovascular changes associated with interleukin-1 beta (IL-1 beta) and histamine (HA) levels in Alzheimer's disease. Ann N Y Acad Sci 1997; 826:375-378. (Pubitemid 27478056)
37. Reale M, Iarlori C, Gambi F, et al. Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients. Exp Gerontol 2005; 40:165-171. (Pubitemid 40343007)
38. Cassuto J, Sinclair R, Bonderovic M. Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand 2006; 50:265-282.
39. Wright JL, Durieux ME, Groves DS. A brief review of innovative uses for local anesthetics. Curr Opin Anaesthesiol 2008; 21:651-656.
40. Adams SD, Radhakrishnan RS, Helmer KS, et al. Effects of anesthesia on lipopolysaccharide-induced changes in serum cytokines. J Trauma 2008; 65:170-174.
41. Chiang N, Schwab JM, Fredman G, et al. Anesthetics impact the resolution of inflammation. PLoS One 2008; 3:e1879.
42. Xu X, Kim JA, Zuo Z. Isoflurane preconditioning reduces mouse microglial activation and injury induced by lipopolysaccharide and interferon-gamma. Neuroscience 2008; 154:002-1008.
43. Kim JA, Li L, Zuo Z. Delayed treatment with isoflurane attenuates lipopolysaccharide and interferon gamma-induced activation and injury of mouse microglial cells. Anesthesiology 2009; 111:566-573.
44. Wu X, Lu Y, Dong Y, et al. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-alpha, IL-6, and IL-1beta. Neurobiol Aging 2010 [Epub ahead of print].
45. Wan Y, Xu J, Ma D, et al. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 2007; 106:436-443. (Pubitemid 46662208)
46. Lu Y, Wu X, Dong Y, et al. Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology 2010; 112:1404-1416.
47. Terrando N, Monaco C, Ma D, et al. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A 2010; 107:20518-20522.
48. Cibelli M, Fidalgo AR, Terrando N, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 2010; 68:360-368.
49. Ben-Nathan D, Kobiler D, Rzotkiewicz S, et al. CNS penetration by noninvasive viruses following inhalational anesthetics. Ann N Y Acad Sci 2000; 917:944-950.
50. Tetrault S, Chever O, Sik A, et al. Opening of the blood-brain barrier during isoflurane anaesthesia. Eur J Neurosci 2008; 28:1330-1341.
51. Lehmberg J, Waldner M, Baethmann A, et al. Inflammatory response to nitrous oxide in the central nervous system. Brain Res 2008; 1246:88-95.
52. Zhang H, Astrof NS, Liu JH, et al. Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J 2009; 23:2735-2740.
53. Yuki K, Astrof NS, Bracken C, et al. Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology 2010; 113:600-609.
54. Kohl BA, Deutschman CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care 2006; 12:325-332. (Pubitemid 44078145)
55. Buller KM. Role of circumventricular organs in pro-inflammatory cytokineinduced activation of the hypothalamic-pituitary-adrenal axis. Clin Exp Pharmacol Physiol 2001; 28:581-589. (Pubitemid 32588436)
56. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010; 37:26-32.
57. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009; 118:103-113.
58. Rosczyk HA, Sparkman NL, Johnson RW. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp Gerontol 2008; 43:840-846.
59. Cao XZ, Ma H, Wang JK, et al. Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Prog Neuropsychopharmacol Biol Psychiatry 2010 [Epub ahead of print]. Surgery in aged animals increases neuroinflammation and cognitive dysfunction.
60. Sauer AM, Kalkman C, van DD. Postoperative cognitive decline. J Anesth 2009; 23:256-259.
61. Tsai TL, Sands LP, Leung JM. An update on postoperative cognitive dysfunction. Adv Anesth 2010; 28:269-284.
62. Avidan MS, Searleman AC, Storandt M, et al. Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness. Anesthesiology 2009; 111:964-970.
63. Ramlawi B, Rudolph JL, Mieno S, et al. C-reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Surgery 2006; 140:221-226. (Pubitemid 44176059)
64. Kalman J, Juhasz A, Bogats G, et al. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int 2006; 48:177-180. (Pubitemid 43083620)
65. Palotas A, Reis HJ, Bogats G, et al. Coronary artery bypass surgery provokes Alzheimer's disease-like changes in the cerebrospinal fluid. J Alzheimers Dis 2010 (in press) [Epub ahead of print].
66. Wan Y, Xu J, Meng F, et al. Cognitive decline following major surgery is associated with gliosis, beta-amyloid accumulation, and tau phosphorylation in old mice. Crit Care Med 2010; 38:2190-2198.
67. Bianchi SL, Tran T, Liu C, et al. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging 2008; 29:1002-1010. (Pubitemid 351711665)
68. Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39:409-421. (Pubitemid 36937044)
69. Tang JX, Mardini F, Caltagarone BM, et al. Anesthesia in presymptomatic Alzheimer Disease: A 3xTgAD study. Alzheimers Dement (in press).
70. Planel E, Bretteville A, Liu L, et al. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J 2009; 23:2595-2604.